
Endogenous in-session cortisol during exposure therapy predicts symptom improvement: Preliminary results from a scopolamine-augmentation trial
Kuhlman, Kate R., Treanor, Michael, Imbriano, Gabriella, Craske, Michelle G.Volume:
116
Journal:
Psychoneuroendocrinology
DOI:
10.1016/j.psyneuen.2020.104657
Date:
June, 2020
Fichier:
PDF, 1.20 MB
2020